---
title: "An Study Investigating Nic's Keto Diet on Cardiovascular Health in Healthy Adults With Mildly Elevated LDL Levels"
nct_id: NCT04195594
overall_status: COMPLETED
phase: NA
sponsor: TRC GEN+ managed by Trans Russian co Cy
study_type: INTERVENTIONAL
primary_condition: Ketogenic Dieting
countries: Canada
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT04195594.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT04195594"
ct_last_update_post_date: 2021-05-04
last_seen_at: "2026-05-12T07:07:26.586Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# An Study Investigating Nic's Keto Diet on Cardiovascular Health in Healthy Adults With Mildly Elevated LDL Levels

**Official Title:** An Open Label Study to Investigate the Efficacy of Nic's Keto Diet on Cardiovascular Health in Healthy Adults With Mildly Elevated LDL Levels

**NCT ID:** [NCT04195594](https://clinicaltrials.gov/study/NCT04195594)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 14
- **Lead Sponsor:** TRC GEN+ managed by Trans Russian co Cy
- **Collaborators:** KGK Science Inc.
- **Conditions:** Ketogenic Dieting, Healthy
- **Start Date:** 2020-01-14
- **Completion Date:** 2020-10-13
- **CT.gov Last Update:** 2021-05-04

## Brief Summary

The present study will investigate the effects of Nic's Ketogenic diet, comprised of 70% fat, 5% carbohydrate, and 25% protein on middle-aged males and females with mid-range elevated LDL. With the mixed evidence on the causative effect of LDL cholesterol on increased cardiovascular health risk, further studies are warranted to examine the relation of elevated LDL and other biomarkers of cardiovascular health in response to a lifestyle intervention. Furthermore, this study will investigate weight loss and body composition changes with adherence to this dietary intervention over a 140-day period. In this study the efficacy of Nic's Ketogenic diet on weight loss and biomarkers of cardiovascular health will be examined.

## Eligibility

- **Minimum age:** 30 Years
- **Maximum age:** 55 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

1. Provided voluntary, written, informed consent to participate in study
2. Males and females between 30 and 55 years of age
3. BMI between 20.0 to 29.9 kg/m2, inclusive
4. Female participant is not of child-bearing potential, defined as females who have undergone a sterilization procedure (e.g. hysterectomy, bilateral oophorectomy, bilateral tubal ligation, total endometrial ablation) Or,

   Females of child-bearing potential must have a negative baseline urine pregnancy test and agree to use a medically approved method of birth control for the duration of the study. Acceptable methods of birth control include:
   * Non hormonal contraceptives
   * Double-barrier method
   * Intrauterine devices
   * Non-heterosexual lifestyle or agrees to use contraception if planning on changing to heterosexual partner(s)
   * Vasectomy of partner at least 6 months prior to screening
5. Subjects with mid-range (2.5-4.1mmol/L or 100-159 mg/dL) elevated LDL-C levels
6. Agrees to maintain current level of physical activity throughout the study
7. Willingness to complete all questionnaires, records, and diaries and assessments associated with the study and to complete all clinic visits.
8. Healthy as determined by medical history, laboratory results, and as assessed by Qualified Investigator (QI)

Exclusion Criteria:

1. Women who are pregnant, breast feeding, or planning to become pregnant during the course of the trial
2. Women who are menopausal or post-menopausal
3. Currently following a diet (i.e. Ketogenic Diet, low-carbohydrate diet)
4. Subjects with high TSH level (\>4.5mU/L) or Self reported pre-existing thyroid condition. Treatment on a stable dose of medication for at least 3 months will be considered by the QI
5. Participants with type I or II Diabetes Mellitus
6. Cancer, except skin cancers completely excised with no chemotherapy or radiation with a follow up that is negative. Volunteers with cancer in full remission for more than five years after diagnosis are acceptable.
7. Participants with previous or current pathology of the pancreas
8. Current or history of Gastroesophageal reflux disease (GERD) or any significant disease of the gastrointestinal tract
9. Self reported hypertension or on hypertensives.
10. Significant cardiovascular event in the past 6 months as assessed by the QI.
11. Major surgery in the past 3 months or individuals who have planned surgery during the course of the trial. Participants with minor surgery will be considered on a case-by-case basis by the QI
12. Gastric bypass surgery
13. Individuals with an autoimmune disease or are immune-compromised
14. Self reported HIV-, Hepatitis B- and/or C-positive diagnosis
15. History of or current diagnosis with kidney and/or liver diseases as assessed by the QI on a case-by-case basis, with the exception of history of kidney stones symptom free for 6 months
16. Self reported medical or neuropsychological condition and/or cognitive impairment that, in the QI's opinion, could interfere with study participation
17. Self reported blood/bleeding disorders as per QI
18. Current use of prescribed medications listed in Section 7.3.1
19. Current use of over-the-counter medications, supplements, foods, and/or drinks listed in Section 7.3.2
20. Alcohol or drug abuse within the last 12 months
21. High alcohol intake (\>2 standard drinks per day or \>10 standard drinks per week)
22. Clinically significant abnormal laboratory results at screening as assessed by the QI
23. Metal implants that may affect the DEXA scan results will be assessed on case-by-case basis by the QI
24. Blood donation 30 days prior to screening, during the study, or a planned donation within 30-days of the last study visit
25. Participation in a clinical research trial within 30 days of study initiation
26. Individuals who are unable to give informed consent
27. Any other active or unstable medical condition, that, in the opinion of the QI, may adversely affect the participant's ability to complete the study or its measures or may pose significant risk to the participant
```

## Arms

- **Nic's Keto Diet** (EXPERIMENTAL)

## Interventions

- **Nic's Keto Diet** (OTHER) — Participants will be instructed to follow Nic's keto diet plan for 140 days. They will be asked to not exceed 20 g of carbohydrates (up to 5% caloric intake) and to consume the remaining 70% of calories from fat sources and 25% from protein sources.

## Primary Outcomes

- **Changes to Body Fat Percentage as Assessed by DEXA Scan From Baseline to Day 70 Following Nic's Keto Diet** _(time frame: 70 days)_ — The DEXA scan is a form of X-ray radiation that measures the body tissue density, which was reported at baseline and compared to day 70.
- **Changes to Muscle Mass Percentage as Assessed by DEXA Scan From Baseline to Day 70 Following Nic's Keto Diet** _(time frame: 70 days)_ — The DEXA scan is a form of X-ray radiation that measures the body tissue density, which was reported at baseline and compared to day 70.
- **Changes to Body Fat Percentage as Assessed by DEXA Scan From Baseline to Day 140 Following Nic's Keto Diet** _(time frame: 140 days)_ — The DEXA scan is a form of X-ray radiation that measures the body tissue density, which was reported at baseline and compared to day 140.
- **Changes to Muscle Mass Percentage as Assessed by DEXA Scan From Baseline to Day 140 Following Nic's Keto Diet** _(time frame: 140 days)_ — The DEXA scan is a form of X-ray radiation that measures the body tissue density, which was reported at baseline and compared to day 140.
- **Changes to Weight as Assessed by BMI From Baseline to Day 70 Following Nic's Keto Diet** _(time frame: 70 days)_ — Changes to weight as assessed by BMI was reported at baseline and compared to day 70.
- **Changes to Weight as Assessed by BMI From Baseline to Day 140 Following Nic's Keto Diet** _(time frame: 140 days)_ — Changes to weight as assessed by BMI was reported at baseline and compared to day 140.

## Secondary Outcomes

- **The Change in Inflammation, as Assessed by the Change in Erythrocyte Sedimentation Rate (ESR) Following Nic's Keto Diet for 140 Days** _(time frame: 140 days)_
- **The Change in Inflammation, as Assessed by the Change in C-reactive Protein (CRP) Following Nic's Keto Diet for 140 Days** _(time frame: 140 days)_
- **Changes to Weight From Baseline to Day 28 Following Nic's Keto Diet** _(time frame: 28 days)_
- **Changes to Weight From Baseline to Day 56 Following Nic's Keto Diet** _(time frame: 56 days)_
- **Changes to Weight From Baseline to Day 84 Following Nic's Keto Diet** _(time frame: 84 days)_
- **Changes to Weight From Baseline to Day 112 Following Nic's Keto Diet** _(time frame: 112 days)_
- **Changes to Systolic Blood Pressure From Baseline to Day 28 Following Nic's Keto Diet** _(time frame: 28 days)_
- **Changes to Systolic Blood Pressure From Baseline to Day 56 Following Nic's Keto Diet** _(time frame: 56 days)_
- **Changes to Systolic Blood Pressure From Baseline to Day 84 Following Nic's Keto Diet** _(time frame: 84 days)_
- **Changes to Systolic Blood Pressure From Baseline to Day 112 Following Nic's Keto Diet** _(time frame: 112 days)_
- **Changes to Systolic Blood Pressure From Baseline to Day 140 Following Nic's Keto Diet** _(time frame: 140 days)_
- **Changes to Total Cholesterol From Baseline to Day 28 Following Nic's Keto Diet** _(time frame: 28 days)_
- **Changes to Triglyceride Level From Baseline to Day 28 Following Nic's Keto Diet** _(time frame: 28 days)_
- **Changes to HDL-Cholesterol From Baseline to Day 28 Following Nic's Keto Diet** _(time frame: 28 days)_
- **Changes to LDL-Cholesterol From Baseline to Day 28 Following Nic's Keto Diet** _(time frame: 28 days)_
- **Changes to Total Cholesterol From Baseline to Day 56 Following Nic's Keto Diet** _(time frame: 56 days)_
- **Changes to Triglyceride Level From Baseline to Day 56 Following Nic's Keto Diet** _(time frame: 56 days)_
- **Changes to HDL-Cholesterol From Baseline to Day 56 Following Nic's Keto Diet** _(time frame: 56 days)_
- **Changes to LDL-Cholesterol From Baseline to Day 56 Following Nic's Keto Diet** _(time frame: 56 days)_
- **Changes to Total Cholesterol From Baseline to Day 84 Following Nic's Keto Diet** _(time frame: 84 days)_
- **Changes to Triglyceride Level From Baseline to Day 84 Following Nic's Keto Diet** _(time frame: 84 days)_
- **Changes to HDL-Cholesterol From Baseline to Day 84 Following Nic's Keto Diet** _(time frame: 84 days)_
- **Changes to LDL-Cholesterol From Baseline to Day 84 Following Nic's Keto Diet** _(time frame: 84 days)_
- **Changes to Total Cholesterol From Baseline to Day 112 Following Nic's Keto Diet** _(time frame: 112 days)_
- **Changes to Triglyceride Level From Baseline to Day 112 Following Nic's Keto Diet** _(time frame: 112 days)_
- **Changes to HDL-Cholesterol From Baseline to Day 112 Following Nic's Keto Diet** _(time frame: 112 days)_
- **Changes to LDL-Cholesterol From Baseline to Day 112 Following Nic's Keto Diet** _(time frame: 112 days)_
- **Changes to Total Cholesterol From Baseline to Day 140 Following Nic's Keto Diet** _(time frame: 140 days)_
- **Changes to Triglyceride Level From Baseline to Day 140 Following Nic's Keto Diet** _(time frame: 140 days)_
- **Changes to HDL-Cholesterol From Baseline to Day 140 Following Nic's Keto Diet** _(time frame: 140 days)_
- **Changes to LDL-Cholesterol From Baseline to Day 140 Following Nic's Keto Diet** _(time frame: 140 days)_
- **Changes to HbA1c From Baseline to Day 140 Following Nic's Keto Diet** _(time frame: 140 days)_
- **Changes to Fasting Glucose From Baseline to Day 140 Following Nic's Keto Diet** _(time frame: 140 days)_
- **Changes to Free Tri-iodothyronine (T3) From Baseline to Day 140 Following Nic's Keto Diet** _(time frame: 140 days)_
- **Changes to Weight From Baseline to Day 70 Following Nic's Keto Diet** _(time frame: 70 days)_
- **Changes to Weight From Baseline to Day 140 Following Nic's Keto Diet** _(time frame: 140 days)_
- **Changes to Systolic Blood Pressure From Baseline to Day 70 Following Nic's Keto Diet** _(time frame: 70 days)_
- **Changes to Diastolic Blood Pressure From Baseline to Day 28 Following Nic's Keto Diet** _(time frame: 28 days)_
- **Changes to Diastolic Blood Pressure From Baseline to Day 56 Following Nic's Keto Diet** _(time frame: 56 days)_
- **Changes to Diastolic Blood Pressure From Baseline to Day 70 Following Nic's Keto Diet** _(time frame: 70 days)_
- **Changes to Diastolic Blood Pressure From Baseline to Day 84 Following Nic's Keto Diet** _(time frame: 84 days)_
- **Changes to Diastolic Blood Pressure From Baseline to Day 112 Following Nic's Keto Diet** _(time frame: 112 days)_
- **Changes to Diastolic Blood Pressure From Baseline to Day 140 Following Nic's Keto Diet** _(time frame: 140 days)_

## Locations (1)

- KGK Science Inc., London, Ontario, Canada

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.kgk science inc.|london|ontario|canada` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT04195594.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT04195594*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*